Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

NCA-0465: new antitumor indoloquinoxaline derivative

Oct. 24, 1997

Cellular target of new antitumor agent from Nippon Shinyaku identified

Oct. 24, 1997

Nikken presents new modulator of multidrug resistance

Oct. 24, 1997

New DC-107 derivative presented at cancer meeting

Oct. 24, 1997

New antimitotic agents presented by Kyowa Hakko

Oct. 24, 1997

Improved DNA topoisomerase poisons discovered at Rutgers

Oct. 24, 1997

VEGF inhibitors described by Zeneca

Oct. 24, 1997

Dusa reports positive phase III results for Levulan PDT

Oct. 24, 1997

Preclinical results with L-methioninase presented at cancer meeting

Oct. 23, 1997

Antiproliferative quinazoline derivatives disclosed at Zeneca

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...